PMID- 18404520 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20110714 LR - 20211020 IS - 1573-9538 (Print) IS - 1573-9546 (Electronic) IS - 1573-9538 (Linking) VI - 1 IP - 4 DP - 2005 Dec TI - The priming effect of extracellular UTP on human neutrophils: Role of calcium released from thapsigargin-sensitive intracellular stores. PG - 359-68 LID - 10.1007/s11302-005-0039-8 [doi] AB - P2Y(2) receptors, which are equally responsive to ATP and UTP, can trigger intracellular signaling events, such as intracellular calcium mobilization and mitogen-activated protein (MAP) kinase phosphorylation in polymorphonuclear leukocytes (PMN). Moreover, extracellular nucleotides have been shown to prime chemoattractant-induced superoxide production. The aim of our study was to investigate the mechanism responsible for the priming effect of extracellular nucleotides on reactive oxygen species (ROS) production induced in human neutrophils by two different chemoattractants: formyl-methionyl-leucyl-phenylalanine (fMLP) and interleukin-8 (IL-8). Nucleotide-induced priming of ROS production was concentration- and time-dependent. When UTP was added to neutrophil suspensions prior to chemoattractant, the increase of the response reached the maximum at 1 min of pre-incubation with the nucleotide. UTP potentiated the phosphorylation of p44/42 and p38 MAP kinases induced by chemoattractants, however the P2 receptor-mediated potentiation of ROS production was still detectable in the presence of a SB203580 or U0126, supporting the view that MAP kinases do not play a major role in regulating the nucleotide-induced effect. In the presence of thapsigargin, an inhibitor of the ubiquitous sarco-endoplasmic reticulum Ca(2+)-ATPases in mammalian cells, the effect of fMLP was not affected, but UTP-induced priming was abolished, suggesting that the release of calcium from thapsigargin-sensitive intracellular stores is essential for nucleotide-induced priming in human neutrophils. FAU - Tuluc, Florin AU - Tuluc F AD - Department of Physiology, Temple University Medical School, Philadelphia, Pennsylvania, USA. FAU - Bredetean, Ovidiu AU - Bredetean O FAU - Brailoiu, Eugen AU - Brailoiu E FAU - Meshki, John AU - Meshki J FAU - Garcia, Analia AU - Garcia A FAU - Dun, Nae J AU - Dun NJ FAU - Kunapuli, Satya P AU - Kunapuli SP LA - eng GR - R01 HL063933/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20051203 PL - Netherlands TA - Purinergic Signal JT - Purinergic signalling JID - 101250499 PMC - PMC2096557 EDAT- 2008/04/12 09:00 MHDA- 2008/04/12 09:01 PMCR- 2005/12/03 CRDT- 2008/04/12 09:00 PHST- 2005/02/22 00:00 [received] PHST- 2005/06/03 00:00 [accepted] PHST- 2005/04/26 00:00 [revised] PHST- 2008/04/12 09:00 [pubmed] PHST- 2008/04/12 09:01 [medline] PHST- 2008/04/12 09:00 [entrez] PHST- 2005/12/03 00:00 [pmc-release] AID - 20039 [pii] AID - 10.1007/s11302-005-0039-8 [doi] PST - ppublish SO - Purinergic Signal. 2005 Dec;1(4):359-68. doi: 10.1007/s11302-005-0039-8. Epub 2005 Dec 3.